Skip to main content
OpenTrials

Clinical trial condition

Uterine Cervical Neoplasms

Explore clinical trials studying Uterine Cervical Neoplasms. Study availability and eligibility vary by location and protocol.

1,588 public trials 355 recruiting studies
Refine in advanced search Browse all conditions

Uterine Cervical Neoplasms trial results

Recruiting

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

NCT06047379

Conditions
Adenocarcinoma, Astrocytoma, Brain Diseases, +93 more
Locations
  • Precision NextGen Oncology Beverly Hills, California, United States
  • OPN Healthcare, Inc Glendale, California, United States
  • University of Southern California Los Angeles, California, United States
  • MDR Core Network Boynton Beach, Florida, United States
View Trial Details
Recruiting

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)

NCT07281430

Conditions
Cervical Carcinoma, Communicable Diseases, DNA Virus Infections, +23 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Louisiana State University Lafayette, Louisiana, United States
  • Louisiana State University Health Science Center New Orleans, Louisiana, United States
View all 18 locations
View Trial Details
Recruiting

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

NCT06760819

Conditions
Adnexal Diseases, Advanced Solid Tumors, Biliary Tract Diseases, +53 more
Locations
  • UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • City of Hope - Duarte Cancer Center Duarte, California, United States
  • Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus Fort Myers, Florida, United States
  • Dana-Farber Cancer Institute - Oncology Department Boston, Massachusetts, United States
View all 54 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

NCT05581004

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +57 more
Locations
  • Stanford University San Francisco, California, United States
  • University Of Colorado Aurora, Colorado, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • Winship Cancer Institute Atlanta, Georgia, United States
View all 41 locations
View Trial Details
Recruiting

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

NCT05768139

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +40 more
Locations
  • Ellison Clinic at Saint John's Los Angeles, California, United States
  • UCSF Medical Center at Mission Bay San Francisco, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Yale-New Haven Hospital New Haven, Connecticut, United States
View all 65 locations
View Trial Details

Related conditions